Perimenopausal Women with HIV Experience Worse COVID-19 Symptoms
Out of the three stages of menopause, perimenopausal women living with HIV experience the worst COVID-19 symptoms, possibly due to increased inflammation.
menopause © Bovart - stock.adobe.com
Women living with HIV experience the worst COVID-19 symptoms during perimenopause, when compared with premenopause and postmenopause, the results of a recent survey show. This may be due to an increased state of inflammation caused by a combination of HIV, COVID-19 and menopause.
To come to this conclusion, a team of researchers led by Emily M. Cherenack, Ph.D., a post-doctoral associate at the University of Miami, used survey data from 2020 to 2022 from the Multicenter AIDS Cohort Study and Women's Interagency HIV Study to identify 880 women living with HIV and categorized them by menopause state and compared COVID-19 test results and symptoms.
Out of 880 women, 16% (138) were premenopausal, 8% (59) perimenopausal and 78% (683) postmenopausal. Although only 9% (78) tested positive for COVID-19, over half (59%) of perimenopausal women experienced hot flashes during COVID-19 while 33% of premenopausal women and 43% postmenopausal women reported hot flashes. The same can be said about night sweats, which are nocturnal hot flashes. Almost half (44%) of perimenopausal women with COVID-19 reported night sweats, while 28% of premenopausal women and 31% of postmenopausal women said they had night sweats during COVID-19.
Other symptoms, such as fatigue, were also more present in perimenopausal women with COVID-19 (83%) when compared with premenopausal and postmenopausal women combined (45%). Perimenopausal women also experienced more sore throats (61% vs 25%), aches (78% vs 43%) and smell loss (67% vs 25%).
COVID-19 infections and menopause stage (premenopause, perimenopause and postmenopause) were both self- reported.
Perimenopause typically begins for women in their early to mid 40’s. It is often the most symptomatic stage of menopause, marked by irregular periods, brain fog and hot flashes.
Previous limited research suggests that women living with HIV may also experience menopause sooner and have more severe menopause symptoms.
“Despite the potential health impacts of these co-occurring conditions and the possibility of some overlapping symptoms, little is known about the associations between menopause and COVID-19 among women living with HIV,” Cherenack and her team write. “Research is needed to explore if hormonal and behavioral changes in menopause are associated with immune responses to infectious disease among women living with HIV.”
The full details of this study will be presented at the 2024 Annual Meeting of the Menopause Society held September 10 – 14.
Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent
June 19th 2025Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be available to the people who would benefit most from HIV PrEP?
Read More
Trump Budget Axes CDC HIV Prevention, Shifts Care, Experts Warn of Risks
June 10th 2025Although some HIV programs will remain, the proposed cuts in the fiscal year 2026 budget are too severe and will hinder HIV care and research in the United States, according to Carl Schmid, executive director of the HIV+Hepatitis Policy Institute in Washington, D.C.
Read More
Most HIV Patients Trust Their Providers But Don’t Always Feel Heard, Survey Says
May 27th 2025Almost half (48%) of HIV patients sometimes feel unheard by their healthcare providers, which highlights a need for increased disease awareness, according to the early results of a new ViiV Healthcare survey.
Read More
